AURENA Trademark

Trademark Overview


On Wednesday, April 5, 2023, a trademark application was filed for AURENA with the United States Patent and Trademark Office. The USPTO has given the AURENA trademark a serial number of 97874083. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Monday, January 1, 2024. This trademark is owned by Teva Pharmaceuticals International GmbH. The AURENA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders, pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations
aurena

General Information


Serial Number97874083
Word MarkAURENA
Filing DateWednesday, April 5, 2023
Status641 - NON-FINAL ACTION - MAILED
Status DateMonday, January 1, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders, pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, April 8, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameTeva Pharmaceuticals International GmbH
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJona 8645
CH

Trademark Events


Event DateEvent Description
Monday, January 1, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, January 1, 2024NON-FINAL ACTION E-MAILED
Monday, January 1, 2024NON-FINAL ACTION WRITTEN
Monday, January 1, 2024ASSIGNED TO EXAMINER
Saturday, April 29, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, April 8, 2023NEW APPLICATION ENTERED